Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951 (Q34990522)

5 August 2017

title

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951 (English)

1 reference

5 August 2017

main subject

phase III clinical trial

0 references

1 reference

3

Mathilde Kouwenhoven

1 reference

5 August 2017

Ahmed Idbaih

1

0 references

Olivier Delattre

object named as

Olivier Delattre

11

0 references

Thierry Gorlia

6

object named as

Thierry Gorlia

1 reference

5 August 2017

7

Johan M Kros

1 reference

5 August 2017

Martin J van den Bent

15

object named as

Martin van den Bent

1 reference

5 August 2017

13

Marc Sanson

1 reference

5 August 2017

14

Jean-Yves Delattre

1 reference

5 August 2017

12

Karima Mokhtari

1 reference

5 August 2017

16

Khê Hoang-Xuan

1 reference

5 August 2017

5

Catherine Carpentier

1 reference

5 August 2017

Cyril Dalmasso

2

1 reference

5 August 2017

Judith Jeuken

4

1 reference

5 August 2017

Pim French

8

1 reference

5 August 2017

Johannes Teepen

9

1 reference

5 August 2017

Philippe Broët

10

1 reference

5 August 2017

publication date

6 September 2010

1 reference

Journal of Neuro-Oncology

5 August 2017

published in

1 reference

5 August 2017

volume

103

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

221-230

1 reference

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Malignant gliomas in adults

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

A mixture model approach to multiple testing for the genetic analysis of gene expression.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

The 2007 WHO classification of tumours of the central nervous system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

CAPweb: a bioinformatics CGH array Analysis Platform

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Molecular genetics of oligodendrogliomas: a model for improved clinical management in the field of neurooncology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Molecular classification of human gliomas using matrix-based comparative genomic hybridization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Characterization of the 1p/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

The WHO classification of tumors of the nervous system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Glioma classification: a molecular reappraisal

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

8 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Two types of chromosome 1p losses with opposite significance in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

OLIG2 as a specific marker of oligodendroglial tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Identification of consistent novel submegabase deletions in low-grade oligodendrogliomas using array-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

High-resolution genome-wide mapping of genetic alterations in human glial brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0380-9

Gene dosage and mutational analyses of EGFR in oligodendrogliomas

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097344

Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20820870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20820870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-010-0380-9

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference